E

EdiTy Therapeutics

19 employees

EdiTy Therapeutics is a biotechnology company that develops a gene-editing technology designed for in-vivo gene-editing of target cells.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
cancer
Therapeutics
gene therapy
Medical Device
Genetics
cell therapy
gene editing
drug delivery

Date founded

2020

Funding rounds raised

E

EdiTy Therapeutics raised undisclosed on July 12, 2022

Investors: Reinforced Ventures

E

EdiTy Therapeutics raised undisclosed on March 1, 2021

Investors: Tal Ventures

FAQ